Description
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer(TM) MYD88 Mutation Testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
TAT:
Specimen Type:
Genomics Single Test
Other Tests
-
263%
MPL Mutation Detection
Exon 10
-
264%
OncQuer TM Myeloid Panel (1-3 markers)
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM Myeloid Panel (1-3 markers)
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
264%
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
264%
OncQuer TM Scout LB 56 Gene Test
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM Scout LB 56 Gene Test
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
Reviews
There are no reviews yet.